High-Flow Nasal Cannula oxygen therapy in COVID-19: retrospective analysis of clinical outcomes – single center experience

High-Flow Nasal Cannula oxygen therapy in COVID-19: retrospective analysis of clinical outcomes – single center experience

BackgroundHigh-Flow Nasal Cannula (HFNC) oxygen therapy emerged as the therapy of choice in COVID-19-related pneumonia and moderate to severe acute hypoxemic respiratory failure (AHRF). HFNC oxygen therapy in COVID-19 has been recommended based its use to treat AHRF of other etiologies, and studies...

Full description

Bibliographic Details
Main Authors: Dušanka Obradović, Aleksandra Milovančev, Aleksandra Plećaš Đurić, Stanislava Sovilj-Gmizić, Vladimir Đurović, Jovica Šović, Miloš Đurđević, Stevan Tubić, Jelena Bulajić, Milena Mišić, Jovana Jojić, Miroslava Pušara, Ivana Lazić, Mladen Đurković, Renata Bek Pupovac, Aleksandra Vulić, Marija Jozing
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Medicine
Subjects:
COVID-19
acute hypoxemic respiratory failure
High-Flow Nasal Cannula oxygen therapy
clinical outcomes
intensive care unit
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1244650/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1244650/full

Similar Items